RxDoctor Payments Data

Barbara Haley

Hematology & Oncology · Dallas, TXNPI 1518936087

Payments from drug & device makers

$1,631,581in general payments, 2019–2025

Across 239 payments — averaging $6826.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Puma Biotechnology, Inc.$410K
  • Daiichi Sankyo Inc.$211K
  • Pfizer$189K
  • Seagen Inc.$157K
  • Eli Lilly$143K
  • Genentech, Inc.$117K
  • plus $405K from 10 others
$4,740in research payments, 2019–2025

Across 4 payments — averaging $1185.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$5K

What the payments were for

  • Food & beverage$5281%
  • Education$1219%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Puma Biotechnology, Inc.68$409,816
Daiichi Sankyo Inc.62$210,753
Pfizer5$188,872
Seagen Inc.11$156,731
Eli Lilly6$143,427
Genentech, Inc.17$116,502
Roche Products Limited21$99,251
GSK8$84,260
Daiichi Sankyo Company LTD6$65,035
Astrazeneca UK Limited4$53,725
Sanofi US Services Inc.4$37,580
AbbVie12$31,892
Merck4$16,350
Macrogenics, Inc.7$12,234
Novartis3$5,140
Gilead1$12

How this compares

$1,631,581 in reported general payments places this provider in the 90th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas

Other hematology & oncology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →